Regardless, although the kinetics of the intraclonal CXCR4/CD5 CLL fractions are more complex than originally appreciated, there still appears to be a progressive change, starting from the PF (or the DDF) and ending in the RF. The gene discussed is CD5; the disease is B-cell chronic lymphocytic leukemia.